Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s Laboratories launches generic Carboprost Tromethamine injection

Date: 07-12-2019

Dr. Reddy's Laboratories has launched in the US generic Carboprost Tromethamine injection used for aborting pregnancy. The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market. The product is a generic version of Pfizer's Hemabate injection in the strength of 250mcg/mL.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharm aceuticals in India and overseas.